SEC CIK 1326969
Bedrosian Camille L
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| RAREview stock → | 46,720 | 2023-03-01 |
| RYTMview stock → | 7,000 | 2025-06-18 |
| CRNXview stock → | 0 | 2026-09-01 |
Position History — RARE
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — RARE
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2023-03-01 | Open-market sale | 3,881 | $45.25 | 46,720 |
| 2023-03-01 | Grant / award | 2,663 | $0.00 | 50,601 |
| 2022-03-01 | Grant / award (derivative) | 24,900 | $0.00 | 24,900 |
| 2022-03-01 | Grant / award | 14,000 | $0.00 | 47,938 |
| 2022-03-01 | Open-market sale | 2,821 | $66.62 | 33,938 |
| 2022-01-30 | Open-market sale | 1,657 | $66.30 | 36,759 |
| 2021-10-14 | Open-market sale | 359 | $81.14 | 38,416 |
| 2021-09-02 | Option exercise (derivative) | 2,500 | $0.00 | 53,000 |
| 2021-09-02 | Open-market sale | 2,500 | $100.18 | 38,775 |
| 2021-09-02 | Option exercise | 2,500 | $55.00 | 41,275 |
| 2021-09-01 | Option exercise (derivative) | 2,500 | $0.00 | 55,500 |
| 2021-09-01 | Open-market sale | 2,500 | $100.03 | 38,775 |
| 2021-09-01 | Option exercise | 2,500 | $55.00 | 41,275 |
| 2021-05-06 | Open-market sale | 364 | $113.67 | 38,775 |
| 2021-04-15 | Option exercise (derivative) | 5,000 | $0.00 | 58,000 |
| 2021-04-15 | Open-market sale | 5,000 | $109.09 | 39,139 |
| 2021-04-15 | Option exercise | 5,000 | $55.00 | 44,139 |
| 2021-03-01 | Grant / award (derivative) | 11,000 | $0.00 | 11,000 |
| 2021-03-01 | Grant / award | 4,636 | $0.00 | 43,682 |
| 2021-03-01 | Open-market sale | 4,543 | $138.18 | 39,139 |
| 2021-03-01 | Grant / award | 5,500 | $0.00 | 39,046 |
| 2021-01-30 | Open-market sale | 2,243 | $140.36 | 33,546 |
| 2021-01-15 | Option exercise (derivative) | 25,000 | $0.00 | 63,000 |
| 2021-01-15 | Open-market sale | 25,000 | $139.18 | 35,789 |
| 2021-01-15 | Option exercise | 25,000 | $55.00 | 60,789 |
| 2020-10-14 | Open-market sale | 262 | $88.00 | 35,789 |
| 2020-05-06 | Tax withholding | 249 | $66.26 | 36,051 |
| 2020-03-01 | Grant / award (derivative) | 21,000 | $0.00 | 21,000 |
| 2020-03-01 | Tax withholding | 1,249 | $56.08 | 36,300 |
| 2020-03-01 | Grant / award | 5,634 | $0.00 | 37,549 |
| 2020-03-01 | Grant / award | 7,300 | $0.00 | 31,915 |
| 2020-01-30 | Tax withholding | 1,624 | $53.23 | 24,615 |
| 2019-10-14 | Grant / award | 1,437 | $0.00 | 26,239 |
| 2019-05-06 | Grant / award | 1,438 | $0.00 | 24,802 |
| 2019-03-01 | Grant / award (derivative) | 21,500 | $0.00 | 21,500 |
| 2019-03-01 | Grant / award | 7,000 | $0.00 | 23,364 |
| 2019-01-30 | Tax withholding | 1,636 | $48.85 | 16,364 |
| 2018-01-30 | Grant / award (derivative) | 88,000 | $0.00 | 88,000 |
| 2018-01-30 | Grant / award | 18,000 | $0.00 | 18,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.